Hi Tech Pharmacal Co Inc (HITK) Financial Statements (2024 and earlier)

Company Profile

Business Address 369 BAYVIEW AVENUE
AMITYVILLE, NY 11701
State of Incorp. NY
Fiscal Year End April 30
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

1/31/2014
Q3
10/31/2013
Q2
7/31/2013
Q1
4/30/2013
Q4
1/31/2013
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments108,838108,283100,61087,598
Cash and cash equivalents108,838108,283100,61087,598
Receivables69,01661,11063,77574,736
Inventory, net of allowances, customer advances and progress billings45,87944,73639,22939,427
Inventory45,87944,73639,22939,427
Prepaid expense1,043  
Prepaid expense and other current assets7,450
Other current assets3,2272,3793,622
Other undisclosed current assets13,38113,03212,3215,755
Total current assets:241,384229,540219,557214,966
Noncurrent Assets
Property, plant and equipment35,01134,70632,16831,230
Intangible assets, net (including goodwill), including:39,97941,60440,88742,168
Intangible assets, net (excluding goodwill)39,97941,604 42,168
Other undisclosed intangible assets, net (including goodwill)40,887
Other noncurrent assets308358428
Prepaid expense and other noncurrent assets295
Other undisclosed noncurrent assets2,5031,4101,956 
Total noncurrent assets:77,80178,07875,43973,693
TOTAL ASSETS:319,185307,618294,996288,659
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities27,15430,79827,75429,003
Taxes payable  1,4811,061 
Employee-related liabilities   3,288 
Accounts payable13,50815,0089,7689,872
Accrued liabilities13,64614,30913,63719,131
Debt  355355355
Other undisclosed current liabilities29,27519,77515,7872,875
Total current liabilities:56,42950,92843,89632,233
Noncurrent Liabilities
Long-term debt and lease obligation  799888977
Long-term debt, excluding current maturities  799888977
Liabilities, other than long-term debt    1,484
Deferred tax liabilities, net    1,484
Other undisclosed noncurrent liabilities3,5704,2264,8445,452
Total noncurrent liabilities:3,5705,0255,7327,913
Total liabilities:59,99955,95349,62840,146
Equity
Equity, attributable to parent259,186251,665245,368248,513
Common stock164161161161
Treasury stock, value(25,425)(24,301)(24,301)(24,301)
Additional paid in capital110,405102,950101,20399,731
Retained earnings174,042172,855168,305172,922
Total equity:259,186251,665245,368248,513
TOTAL LIABILITIES AND EQUITY:319,185307,618294,996288,659

Income Statement (P&L) ($ in thousands)

1/31/2014
Q3
10/31/2013
Q2
7/31/2013
Q1
4/30/2013
Q4
1/31/2013
Q3
Revenues
(Revenue, Net)
58,60150,50158,47364,331
Cost of revenue
(Cost of Goods and Services Sold)
(27,291)(25,076)(31,182)(31,452)
Gross profit:31,31025,42527,29132,879
Operating expenses(22,000)(20,217)(21,464)(25,738)
Operating income:9,3105,2085,8277,141
Nonoperating expense(29,535)(18,535)(35,564)(23,830)
Interest and debt expense(69)(107)(100)(138)
Other undisclosed income from continuing operations before equity method investments, income taxes22,06920,32421,56425,876
Income (loss) from continuing operations before income taxes:1,7756,890(8,273)9,049
Income tax expense (benefit)(588)(2,340)3,656(3,109)
Income (loss) from continuing operations:1,1874,550(4,617)5,940
Income (loss) before gain (loss) on sale of properties:1,1874,550(4,617)5,940
Net income (loss) available to common stockholders, diluted:1,1874,550(4,617)5,940

Comprehensive Income ($ in thousands)

1/31/2014
Q3
10/31/2013
Q2
7/31/2013
Q1
4/30/2013
Q4
1/31/2013
Q3
Net income (loss):1,1874,550(4,617)5,940
Comprehensive income (loss), net of tax, attributable to parent:1,1874,550(4,617)5,940

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: